+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Endometriosis Treatment Market - Global Forecast 2026-2032- Product Image
Endometriosis Treatment Market - Global Forecast 2026-2032- Product Image
New

Endometriosis Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989704
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The endometriosis treatment market is evolving rapidly, shaped by advances in therapies, modernization of care models, and shifting policy requirements. Senior decision-makers must anticipate these transformations to ensure their organizations remain agile, competitive, and aligned with patient and health system needs.

Market Snapshot: Endometriosis Treatment Market Growth Trajectory

The endometriosis treatment market achieved growth from USD 3.27 billion in 2025 to USD 3.51 billion in 2026 and is projected to reach USD 5.48 billion by 2032, corresponding to a 7.65% CAGR. This rising trajectory underlines heightened demand for innovative care solutions that address both immediate symptom relief and long-term disease management. Growth is driven by heightened awareness among clinicians, expansion of therapy portfolios, and ongoing innovation in treatment methodologies. The sector’s expansion reflects a shifting landscape where new interventions and services are increasingly sought-after to improve quality of life and optimize health outcomes.

The Endometriosis Treatment Market: Scope & Segmentation

This report presents a comprehensive analysis of the endometriosis treatment sector, offering segmentation insights and regional perspectives to inform strategic planning. It dissects new clinical pathways and tracks commercial dynamics spanning diverse healthcare systems.

  • Treatment Types: Includes hormonal approaches such as aromatase inhibitors and GnRH agents, oral contraceptives, complementary therapies, progestins, pain management (NSAIDs, opioids), and surgical treatments, all varying by adoption rates and patient profiles.
  • Route of Administration: Assesses oral, injectable, and topical formulations, highlighting their impact on patient adherence, preference, and operational delivery across various care settings.
  • Care Settings: Encompasses ambulatory surgical centers, hospitals, and specialty clinics with analysis of clinical workflow, reimbursement models, and operational efficiencies central to effective care.
  • Distribution Channels: Reviews hospital, online, and retail pharmacy networks to evaluate access, product uptake, patient support, and the influence on market expansion.
  • Regional Coverage: Profiles the Americas, Europe, Middle East & Africa, and Asia-Pacific, examining diverse regulatory landscapes, infrastructure readiness, and clinical practice differences shaping adoption.
  • Technologies & Trends: Explores digital health integration, telemedicine, cross-specialist teams, and recent diagnostic imaging advances, identifying how technology is transforming patient journeys and care decision-making.

Key Takeaways for Senior Decision-Makers

  • Collaboration across gynecology, pain management, fertility, and mental health is fundamental for continuous patient care and improved long-term outcomes in endometriosis treatment pathways.
  • The landscape of therapeutic innovations is shifting to include targeted interventions that move beyond conventional hormonal options, advancing therapies that address disease mechanisms.
  • Integrated care models and digital platforms are streamlining care processes, minimizing fragmentation, and enabling timely access to specialized expertise for complex cases.
  • Regulatory and payer requirements increasingly center on real-world effectiveness, patient experiences, and value-based assessments, directly impacting which novel treatments prevail in the market.
  • Successful market and clinical deployment must be regionally tailored, respecting differing reimbursement policies and cultural expectations influencing provider and patient behavior.

Tariff Impact on Supply Chain and Accessibility

Recent U.S. tariff adjustments for 2025 are affecting pharmaceutical supply chains. These changes adjust sourcing and cost structures, particularly for imported active ingredients and specialized medical devices used in endometriosis treatment. Larger manufacturers with integrated global operations tend to manage these fluctuations by leveraging economies of scale, while smaller or niche suppliers face higher risks of supply disruptions and tighter margins. In this context, procurement teams increasingly prioritize therapies supported by robust supply continuity, prompting suppliers to communicate their value proposition and reliability more transparently.

Methodology & Data Sources

The analysis draws on clinician interviews, systematic reviews of secondary literature, and in-depth supply chain evaluations. Diverse perspectives from specialty clinicians, payers, and procurement leads are benchmarked against manufacturer and trade data. Triangulation and sensitivity analysis ensure accuracy across regional and policy variations.

Why This Report Matters

  • Provides senior leaders with evidence-based guidance for integrating innovation and supply resilience with policy and clinical requirements in the endometriosis treatment market.
  • Supports tailored commercialization, procurement, and market-entry strategies that reflect complex regional healthcare landscapes and emerging patient expectations.
  • Delivers actionable insights to anticipate market shifts and strengthen sustainable patient access and product positioning.

Endometriosis Treatment Market: Actionable Intelligence for Leaders

The report leverages analytics, observable care delivery trends, and supply dynamics to empower senior stakeholders. It enables leaders to align clinical advancements with accessible, cost-efficient care and provides practical intelligence for robust health outcomes and sustained market position.

Conclusion

Progress in endometriosis treatment relies on aligning scientific development with operational strategy and access planning. Advancements for patients derive from coordinated action across care teams and a responsive approach to evolving market and policy shifts.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Endometriosis Treatment Market, by Treatment Type
8.1. Complementary Therapies
8.2. Hormonal Therapies
8.2.1. Aromatase Inhibitors
8.2.2. Gnrh Agonists
8.2.3. Gnrh Antagonists
8.2.4. Oral Contraceptives
8.2.5. Progestins
8.3. Pain Management
8.3.1. Nsaids
8.3.1.1. Diclofenac
8.3.1.2. Ibuprofen
8.3.1.3. Naproxen
8.3.2. Opioids
8.3.2.1. Codeine
8.3.2.2. Morphine
8.4. Surgical Treatment
9. Endometriosis Treatment Market, by Route Of Administration
9.1. Injectable
9.2. Oral
9.3. Topical
10. Endometriosis Treatment Market, by End User
10.1. Ambulatory Surgical Centers
10.2. Hospitals
10.3. Specialty Clinics
11. Endometriosis Treatment Market, by Distribution Channel
11.1. Hospital Pharmacy
11.2. Online Pharmacy
11.3. Retail Pharmacy
12. Endometriosis Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Endometriosis Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Endometriosis Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Endometriosis Treatment Market
16. China Endometriosis Treatment Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AbbVie Inc.
17.6. Amneal Pharmaceuticals Inc.
17.7. Anika Therapeutics, Inc.
17.8. Astellas Pharma Inc.
17.9. AstraZeneca plc
17.10. Bayer AG
17.11. Beijing Biote Pharmaceutical Co., Ltd.
17.12. Eli Lilly and Company
17.13. Ferring International Center S.A.
17.14. Gedeon Richter Plc
17.15. Janssen Pharmaceuticals
17.16. Johnson & Johnson Services, Inc.
17.17. Kissei Pharmaceutical Co., Ltd.
17.18. Livzon Pharmaceutical Group Inc.
17.19. Merck & Co., Inc.
17.20. Myovant Sciences Ltd.
17.21. Neurocrine Biosciences, Inc.
17.22. Novartis AG
17.23. ObsEva SA
17.24. Pfizer Inc.
17.25. Repros Therapeutics Inc.
17.26. Sanofi S.A.
17.27. Shionogi & Co., Ltd.
17.28. Takeda Pharmaceutical Company Limited
17.29. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ENDOMETRIOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AROMATASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AROMATASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AROMATASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DICLOFENAC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DICLOFENAC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY IBUPROFEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY IBUPROFEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NAPROXEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NAPROXEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY CODEINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY CODEINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY CODEINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY MORPHINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY MORPHINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY MORPHINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. EUROPE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 124. EUROPE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 125. EUROPE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 126. EUROPE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. EUROPE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 142. AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 143. AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 144. AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 145. AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 146. AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 147. AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 161. ASEAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 162. ASEAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 163. ASEAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 165. ASEAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 166. ASEAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. ASEAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. GCC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GCC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 170. GCC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 171. GCC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 172. GCC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 173. GCC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 174. GCC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 175. GCC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. GCC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. BRICS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. BRICS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 188. BRICS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 189. BRICS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 190. BRICS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 191. BRICS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 192. BRICS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 193. BRICS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. BRICS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. G7 ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. G7 ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 197. G7 ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 198. G7 ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 199. G7 ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 200. G7 ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 201. G7 ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202. G7 ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. G7 ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. NATO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. NATO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 206. NATO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 207. NATO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 208. NATO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 209. NATO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 210. NATO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. NATO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. NATO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 223. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 225. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 226. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 227. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2032 (USD MILLION)
TABLE 228. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2032 (USD MILLION)
TABLE 229. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 230. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Endometriosis Treatment market report include:
  • AbbVie Inc.
  • Amneal Pharmaceuticals Inc.
  • Anika Therapeutics, Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Beijing Biote Pharmaceutical Co., Ltd.
  • Eli Lilly and Company
  • Ferring International Center S.A.
  • Gedeon Richter Plc
  • Janssen Pharmaceuticals
  • Johnson & Johnson Services, Inc.
  • Kissei Pharmaceutical Co., Ltd.
  • Livzon Pharmaceutical Group Inc.
  • Merck & Co., Inc.
  • Myovant Sciences Ltd.
  • Neurocrine Biosciences, Inc.
  • Novartis AG
  • ObsEva SA
  • Pfizer Inc.
  • Repros Therapeutics Inc.
  • Sanofi S.A.
  • Shionogi & Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.51 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.48 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Endometriosis Drugs Market - Global Forecast 2026-2032 - Product Image

Endometriosis Drugs Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Endometriosis Market Report 2025 - Product Image

Endometriosis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Endometriosis Pain - Pipeline Insight, 2025 - Product Image

Endometriosis Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Endometriosis Market Report and Forecast 2025-2034 - Product Image

Endometriosis Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Endometriosis Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035 - Product Image

Endometriosis Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035

  • Report
  • 90 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.